论文部分内容阅读
目的:探讨痰热清联合阿奇霉素治疗小儿支气管肺炎的临床疗效。方法:将78例患者随机分成两组,每组39例,对照组采用基本治疗加阿奇霉素,治疗组则采用基本治疗加阿奇霉素联合痰热清,治疗周期为7天,观察两组的临床疗效。结果:治疗组的总体有效率为97.4%,高于对照组的92.3%;治疗组退热时间为(2.11±0.32)d、咳嗽消失平均时间为(2.5±0.54)d以及肺部啰音消失平均时间为(2.8±0.24)d,均较对照组(3.02±0.42),(4.67±0.36),(3.46±0.35)d短,统计分析,差异明显(P<0.05)。结论:痰热清联合阿奇霉素治疗小儿支气管肺炎具有很好的临床疗效,值得的推广应用。
Objective: To investigate the clinical efficacy of Tanreqing combined with azithromycin in the treatment of bronchial pneumonia in children. Methods: 78 patients were randomly divided into two groups, 39 cases in each group. The control group was treated with azithromycin. The treatment group was treated with azithromycin combined with Tanreqing for 7 days. The clinical curative effect was observed. Results: The overall effective rate of the treatment group was 97.4%, which was higher than that of the control group (92.3%). The antipyretic time was (2.11 ± 0.32) days in the treatment group, (2.5 ± 0.54) days and the pulmonary rales disappeared The average time was (2.8 ± 0.24) d, which was significantly shorter than that of the control group (3.02 ± 0.42), (4.67 ± 0.36) and (3.46 ± 0.35) d respectively. The statistical analysis showed significant difference (P <0.05). Conclusion: Tanreqing combined with azithromycin in children with bronchopneumonia has a very good clinical efficacy, it is worth promoting the application.